Nivolumab Monoclonal Antibody from Germany
Nivolumab (Opdivo) human monoclonal antibody inhibits PD-1 for cancer immunotherapy applications. Bulk unmixed under HTS 3002.13.0010 as per immunological product notes for biotech proteins. Not in measured or retail forms.
Duty Rate — Germany → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Validate against WHO biological reference standards in docs
• Use refrigerated containers with continuous monitoring
• Confirm 'unmixed' status excluding solvents beyond water